The overall cost pressure of traditional Chinese medicine enterprises is weakening this year

Business news on January 18 Chengdu Traditional Chinese medicine price index released by the Ministry of Commerce on January 17 shows that in the first quarter, the price of traditional Chinese medicine recovered steadily, up 1.54 points from the end of December 2011, to 110.84 points According to the CPI data released by the National Bureau of statistics on December 12, in December 2011, the prices of traditional Chinese medicine and Chinese patent medicine increased by 9.7%, while the prices of Western medicine decreased by 0.6% and the prices of medical and health care services only increased by 0.5% Long Xingchao, director of the traditional Chinese medicine information center of the China Association of traditional Chinese medicine, told China Securities News on Monday that the recent rise in the price of traditional Chinese medicine was mainly driven by the price of health-care traditional Chinese medicine, and the Spring Festival market played a role in pulling up According to reports, in the near future, Cordyceps increased by more than 8%, and the price of Dangshen increased by more than 10% But on the whole, the price of traditional Chinese medicine in 2012 will be lower than last year, and it is expected to continue to decline Cardiovascular and cerebrovascular medicines led the rise of China Association of traditional Chinese medicine Tiandi network data shows that on January 17, the cardiovascular and cerebrovascular 20 index was 1992.48 points, up 6.22% on a month on month basis, the nourishing 40 index was 2917.44 points, up 1.56% on a month on month basis, and the two kinds of herbs rose the most Dangshen is the most representative It can enhance immunity, dilate blood vessels, reduce blood pressure, improve microcirculation and enhance hemopoietic function In July 2011, the price of the unified product dangshen once exceeded 100 yuan / kg After the national development and Reform Commission made severe control measures in that month, the price of different categories of Dangshen dropped to 35-60 yuan / kg in October According to the data of business agency (100ppi Com), up to now, the price of Dangshen in Gansu Longxi traditional Chinese medicine market has exceeded 70 yuan / kg again, which is more than 15% higher than that in the third quarter of 2011 According to the data on the website of the Ministry of health on July 17, the number of health management of patients with hypertension and diabetes in China has reached 44.7 million and 11.46 million respectively Chronic health care treatment has provided growth space for traditional Chinese medicine products Industry insiders believe that the expansion of market space for health care and cardiovascular and cerebrovascular traditional Chinese medicine makes the Spring Festival an important driving force for the growth of consumption of related traditional Chinese medicine health products The prices of some Chinese herbal medicines with large demand and wide use also rose steadily during the Spring Festival China Securities News reporter learned from Daqing Banlangen planting base in Heilongjiang province that at present, the price of Banlangen is about 5.6-5.7 yuan / kg At the end of 2011, the price is about 5 yuan / kg The person in charge of the place said that Banlangen has the functions of clearing away heat and detoxification, cooling blood and swelling, and can be used in the production of plant drinks Due to the large demand at the end of the year, and the product price fell to a low level last year Point, many manufacturers began to pressure goods, to promote the price rise The pressure of traditional Chinese medicine enterprises is abating Although the price of traditional Chinese medicine rises significantly during the Spring Festival, in the view of the insiders, the overall industry of traditional Chinese medicine will be in a downward atmosphere in 2012 As the production expansion of traditional Chinese medicine planting was large last year, once entering the harvest stage, the price of relevant traditional Chinese medicine will accelerate to decline Since the second half of 2009, the price of traditional Chinese medicine has increased for three consecutive years, and the price of some varieties has doubled several times At the same time, the saying of "up for three years, down for three years, up for three years and down for three years" is popular in the basin of traditional Chinese medicine circulation People in the industry generally believe that with the increase in the supply of domestic medicinal materials, the return of large-scale prices of medicinal materials will be inevitable Long Xingchao predicted that the domestic market for Chinese herbal medicines could be depressed this year and next According to reports, in the next stage, with the stock used up, the price of traditional Chinese medicine will return to reasonable The cost pressure of traditional Chinese medicine enterprises in 2012 is relatively optimistic In addition, the pace of traditional Chinese medicine products entering the EU is expected to accelerate Luo Yang, director of the traditional Chinese Medicine Department of China Chamber of Commerce for the import and export of health care products, told China Securities News on Monday that since 2011, domestic traditional Chinese medicine enterprises have been more active in the registration of traditional Chinese medicine in the European Union Although there is no successful registration of traditional Chinese medicine enterprises, the concentrated Angelica pill of foci Pharmaceutical (002644) has been approved in Sweden After the Spring Festival, it can be determined whether it can be successfully registered in the European Union And Yiling Pharmaceutical (002603) and Tianshili (600535) and other traditional Chinese medicine enterprises are also actively preparing to register According to reports, at present, China's exports of traditional Chinese medicine to the EU are relatively small, with a total amount of less than 20 million US dollars, most of which are plant extracts, Chinese herbal pieces and Chinese herbal health products If the registration of foci pharmaceutical is successful, it will promote the registration of traditional Chinese medicine enterprises in the EU and accelerate the development of domestic traditional Chinese medicine enterprises.